Flovent Discontinuation in 2024 Raises Concerns for Doctors, Patients

Follow Drugslib on

Medically reviewed by Drugs.com.

By Physician’s Briefing Staff HealthDay Reporter

FRIDAY, Dec. 29, 2023 -- In a move that is causing concern among doctors and patients, GlaxoSmithKline is discontinuing Flovent (fluticasone inhalation) as of Jan. 1, 2024.

The pharmaceutical company will make "an authorized generic" version of the drug, but without the same branding. While doctors say it will work just as well, it does not appear to be as widely covered by insurance, according to CNN. As a result, patients may be forced to get new prescriptions and iron out insurance coverage at the peak of respiratory virus season.

"This medication has been the most commonly used inhaled medication for the past 25 or 30 years," Robyn Cohen, M.D., director of the Pediatric Pulmonary and Allergy Clinic at Boston Medical Center, told CNN. "It's the one that, overwhelmingly, pediatricians reach for when they decide that their patient needs a daily preventive medication … The fact that it's being discontinued is going to be a huge shock to the system for patients, for families, and for doctors."

A GSK spokeswoman told CNN the company is making the change "as part of our commitment to be ambitious for patients." She noted the company introduced the authorized generics of Flovent HFA, an inhalation aerosol, and Flovent Diskus, an inhalation powder, in 2022 and 2023 and said it would discontinue the branded versions in the United States on Jan. 1, 2024.

The generics are potentially lower-cost alternatives, the spokeswoman said. But experts on the pharmaceutical industry told CNN that GSK is making the switch at a time when Medicaid rebate changes could saddle the company with large penalties because of previous price hikes on Flovent.

The change going into effect on Jan. 1 removes a cap on Medicaid rebates that pharmaceutical companies must pay if they hike prices more than inflation. Until now, rebates were capped, so manufacturers would never repay Medicaid more than the cost of a drug. Removing that cap means drug makers that have had large price hikes over time could end up selling their medication at a loss.

Since 2014, the price of branded Flovent has risen about 47 percent, according to GoodRx. No other generic versions of the drug are approved by the U.S. Food and Drug Administration. CNN reported that GSK did price the authorized generic lower than the branded Flovent.

CVS Caremark, a major pharmacy benefit manager, is giving preferential placement to another branded inhaler, Pulmicort, instead of generic Flovent. Based on net prices, "in this case, the authorized generics were more expensive than the brand name medications," a CVS spokesman told CNN.

CNN Article

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-12-30 04:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords